Birchler Brian Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$484,824.69

Insider Activity of Birchler Brian

According to the SEC Form 4 filings, Birchler Brian, being in a position of

  1. EVP, Corp and Development Ops at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23632 shares for $1.83M,
    over all time since 2023-04-18, has bought 0 shares, and sold 59686 shares for $4.04M.

Biography of Birchler Brian

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,832,3764100

Comparison of Insiders on Amount of Buys and Sells

2026-04-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
973
0.0006%
$75.04$73,016-22.35%
2026-01-30SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
6,179
0.0038%
$83.03$513,048-12.39%
2026-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
8,480
0.0052%
$75.11$636,933-4.24%
2025-11-06SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
8,000
0.0052%
$76.17$609,379+0.28%
2025-10-15SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
12,425
0.0078%
$72.23$897,398+2.65%
2025-10-14SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
11,475
0.0073%
$72.03$826,589+4.12%
2025-04-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
680
0.0004%
$28.37$19,292+148.43%
2025-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
5,400
0.0034%
$32.70$176,580+29.55%
2024-04-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
905
0.0006%
$41.66$37,698-7.46%
2024-01-17SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
4,497
0.0031%
$50.42$226,725-18.42%
2023-04-18SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Corp and Development Ops
672
0.0005%
$36.50$24,530+18.65%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.